Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Rigel Pharmaceuticals Inc patents

Recent patent applications related to Rigel Pharmaceuticals Inc. Rigel Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Rigel Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Rigel Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Rigel Pharmaceuticals Inc-related inventors




Date Rigel Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
08/03/17Nrf2 activating compounds and uses thereof
08/03/17Nrf2 activating compounds and uses thereof
06/08/17Compositions and methods for inhibition of the jak pathway
06/01/172,4-pyrimidinediamine compounds and their uses
06/01/17Protein kinase c inhibitors and uses thereof
05/18/17Compositions and methods for inhibition of the jak pathway
05/11/17Tetrazolones as a carboxylic acid bioisosteres
05/04/17Compositions and methods for inhibition of the jak pathway
04/06/172,3-disubstituted pyridine compounds as tgf-beta inhibitors and methods of use
03/23/172,4-pyrimidinediamine compounds and their uses
03/09/17Fumarate analogs and uses thereof
02/16/17Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
02/09/17Benzazole compounds and methods for making and using the compounds
12/22/16Prodrugs of 2,4-pyrimidinediamine compounds and their uses
10/27/16Pyrazole compounds and making and using the compounds
09/15/16Gdf-8 inhibitors
09/08/16Protein kinase c inhibitors and uses thereof
09/08/16Tgf-beta inhibitors
08/25/16Substituted triazoles useful as axl inhibitors
08/11/16Ampk-activating heterocyclic compounds and methods for using the same
07/28/16Tetrazolones as a carboxylic acid bioisosteres
05/19/16Prodrugs of 2,4-pyrimidinediamine compounds and their uses
05/05/16Carboxamide compounds and methods for using the same
04/14/16Compositions and methods for inhibition of the jak pathway
03/10/16Ubiquitination inhibitors
03/03/16Protein kinase c inhibitors and uses thereof
02/25/16Gdf-8 inhibitors
02/11/16Fumarate analogs and uses thereof
01/28/16Kinase inhibitors and their uses
01/14/162,4-pyrimidinediamine compounds and their uses
01/14/162,4-pyrimidinediamine compounds and their uses
01/14/162,4-pyrimidinediamine compounds and their uses
12/31/15Protein kinase c inhibitors and uses thereof
11/19/152,4-pyrimidinediamine compounds and their uses
11/05/15Compounds and treating autoimmune diseases
10/29/15Compositions and methods for inhibition of the jak pathway
10/29/15Protein kinase c inhibitors and uses thereof
10/29/15Compositions and methods for inhibition of the jak pathway
09/24/152,4-pyrimidinediamine compounds and their uses
09/17/15Compositions and methods for inhibition of the jak pathway
09/03/15Treatment for vitiligo
08/20/15Carboxamide compounds and methods for using the same
08/06/15Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
06/18/15Whole blood assay for measuring ampk activation
06/11/152,4-pyrimidinediamine compounds and their uses
06/11/152,4-pyrimidinediamine compounds and their uses
06/11/15Compositions and methods for inhibition of the jak pathway
05/14/15Prodrugs of 2,4-pyrimidinediamine compounds and their uses
05/07/152,4-pyrimidinediamine compounds and their uses
05/07/15Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
03/26/15Synthesis of polycyclic alkaloids
03/26/15Methods for using and biomarkers for ampk-activating compounds
03/12/15Substituted triazoles useful as axl inhibitors
01/08/152,4-pyrimidinediamine compounds and uses as anti-proliferative agents
01/08/15Carboxamide compounds and methods for using the same
01/01/152,4-pyrimidinediamine compounds and their uses
12/25/14Carboxamide, sulfonamide and amine compounds and methods for using them
12/11/14Tricyclic carbamate jak inhibitors
12/04/14Prodrugs of 2,4-pyrimidinediamine compounds and their uses
11/06/14Protein kinase c inhibitors and uses thereof
11/06/142,4-pyrimidinediamine compounds and their uses
10/30/14Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/23/14Compositions and methods for inhibition of the jak pathway
10/23/14Ampk-activating heterocyclic compounds and methods for using the same
10/09/142,4-pyridinediamine compounds and their uses
Patent Packs
09/18/14(trimethoxyphenylamino) pyrimidinyl formulations
08/21/14Compositions and methods for inhibition of the jak pathway
08/07/14Compositions and methods for inhibition of the jak pathway
07/31/14Compounds and treating autoimmune diseases
07/31/14Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
07/24/14Composition for ophthalmic administration
06/26/14N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
06/05/14Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
05/29/14Carboxamide compounds and methods for using the same
05/29/14In vivo reporter system
05/08/14Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
04/17/14Gdf-8 inhibitors
03/13/14Treatment for vitiligo
02/20/14Ampk-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
02/13/14Carboxamide, sulfonamide and amine compounds and methods for using the same
Patent Packs
01/30/142,4-pyrimidinediamine compounds and their uses
01/09/14Compositions and methods for inhibition of the jak pathway
12/05/132,4-pyrimidinediamine compounds and their uses
11/21/13Pyrimidinediamine kinase inhibitors
11/21/13Multiparameter facs assays to detect alterations in cellular parameters and to screen small molecule libraries
11/21/13Method of treating muscular degradation
11/21/13Compositions and methods for inhibition of the jak pathway
10/24/13Xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine
10/10/13Model for muscle atrophy
09/12/13Synthesis of polycyclic alkaloids
08/22/13Method for making macrocycles
08/15/13Protein kinase c inhibitors and uses thereof
08/15/13Cycloalkyl substituted pyrimidinediamine compounds and their uses
08/08/13Ampk-activating heterocyclic compounds and methods for using the same
07/25/13Wet granulation using a water sequestering agent
06/13/132,4-pyrimidinediamine compounds and prodrugs and their uses
06/13/13Topical formulation for administering a compound
06/13/132,4-pyrimidinediamine compounds and their uses
06/06/13Compositions and methods for inhibition of the jak pathway
06/06/13Protein kinase c inhibitors and uses thereof
05/02/13Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
04/25/13Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
04/11/13Compositions and methods for inhibition of the jak pathway
04/11/13N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
01/24/13Carboxamide compounds and methods for using the same
01/17/13Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
01/17/13Synthesis of 2,4-pyrimidinediamines
01/10/13Pyrimidinediamine kinase inhibitors
12/13/12Xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine
11/15/12Wet granulation using a water sequestering agent
Social Network Patent Pack
10/18/12Methods for inhibiting allograft rejection
10/18/12Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/04/12Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/27/12Methods of treating cell proliferative disorders
09/13/12Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/13/12Prodrugs of 2,4-pyrimidinediamine compounds and their uses
09/13/12Treatment for discoid lupus
08/23/12Compositions and methods for inhibition of the jak pathway
08/16/12Prodrugs of 2,4-pyrimidinediamine compounds and their uses
05/10/12Ampk-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
Patent Packs
05/03/12Carboxamide, sulfonamide and amine compounds and methods for using the same
05/03/12Prodrugs of 2,4-pyrimidinediamine compounds and their uses
04/12/12Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
02/23/122,4-pyrimidinediamine compounds and their uses
02/23/12Compositions and methods for inhibition of the jak pathway
02/02/12Compositions and methods for inhibition of the jak pathway
02/02/12Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same
01/19/12Kinase inhibitors and their uses
01/19/12Compositions and methods for inhibition of the jak pathway
01/19/12Compositions and methods for inhibition of the jak pathway
01/12/12Compositions and methods for inhibition of the jak pathway
01/12/12Compositions and methods for inhibition of the jak pathway
12/29/11Prodrugs of 2,4-pyrimidinediamine compounds and their uses
12/15/11N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
11/17/11Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
11/03/11Tricyclic carbamate jak inhibitors
10/13/112, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/06/11Methods for using carboxamide, sulfonamide and amine compounds
08/04/112,4-pyrimidinediamine compounds and uses as anti-proliferative agents
07/28/11Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
06/23/11Cycloalkyl substituted pyrimidinediamine compounds and their uses
06/16/11Prodrugs of 2,4-pyrimidinediamine compounds and their uses
06/16/112,4-pyrimidinediamine compounds and their uses
05/26/112,4-pyrimidinediamine compounds and prodrugs and their uses
05/05/11Methods of detecting inhibitors of vif-mediated apobec3g degradation and hiv
05/05/11Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
05/05/11Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
04/28/11Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
04/21/11Diaminothiazoles useful as axl inhibitors
04/07/11Triazole derivatives useful as axl inhibitors
Patent Packs
04/07/11Compositions and methods for inhibition of the jak pathway
03/24/11Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
02/24/11Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
02/03/11Compositions and methods for inhibition of the jak pathway
02/03/11Compositions and methods for inhibition of the jak pathway
01/20/11Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
01/06/11Synthesis of 2,4-pyrimidinediamines
08/05/10Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
08/05/102,4-pyrimidinediamine compounds and their uses
07/29/10Carboxamide compounds and methods for using the same
07/29/10Compositions and methods for inhibition of the jak pathway
07/15/10Pyrimidinediamine kinase inhibitors
07/01/10Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
06/24/10Compositions and methods for inhibition of the jak pathway
06/17/102,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
06/17/10Compositions and methods for inhibition of the jak pathway
05/27/10Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/20/10Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
03/18/10Kinase inhibitors and their uses
02/18/10Compositions and methods for treating inflammatory disorders
Social Network Patent Pack
12/24/09Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/26/09Formulation of insoluble small molecule therapeutics in lipid-based carriers
11/05/09Carboxamide compounds and methods for using the same
10/15/09Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
07/23/09N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
07/09/09Methods of detecting inhibitors of vif-mediated apobec3g degradation and hiv
07/09/09Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
07/02/09Carboxamide, sulfonamide and amine compounds and methods for using the same
07/02/092,4-pyrimidinediamine compounds and their uses
07/02/092,4-pyrimidinediamine compounds and their uses
06/25/09Carboxamide, sulfonamide and amine compounds and methods for using the same
06/18/092,4-pyrimidinediamine compounds and their uses
05/28/09Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
05/28/09Rhodanine compositions for use as antiviral agents
05/14/09Wet granulation using a water sequestering agent
05/14/09Prodrugs of 2,4-pyrimidinediamine compounds and their uses
04/30/09Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
04/23/09Phenylalanine enamide derivatives
04/09/094-pyrimidineamine compounds and uses as anti-proliferative agents
04/02/09Combination therapy with syk kinase inhibitor
Social Network Patent Pack
03/26/092,4-pyrimidinediamine compounds and their uses
03/05/09Spiro 2,4 pyrimidinediamine compounds and their uses
02/19/09Methods for treating renal tumors using 2, 4-pyrimidinediamine drug and prodrug compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Rigel Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Rigel Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';